We are live on ! Find out more
BBP icon

Virtus Biotech ETF
BBP

19 hedge funds and large institutions have $8.57M invested in Virtus Biotech ETF in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

12% more funds holding

Funds holding: 17 → 19 (+2)

3.1% more ownership

Funds ownership: 32.01% → 35.11% (+3.1%)

21% less capital invested

Capital invested by funds: $10.9M → $8.57M (-$2.32M)

43% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 7

Holders
19
Holders Change
+2
Holders Change %
+11.76%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
7
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
+$757K
2
AWCI
Alpine Woods Capital Investors
New York
+$323K
3
PAG
Private Advisor Group
New Jersey
+$229K
4
SMG
Smart Money Group
Texas
+$180K
5
Citadel Advisors
Citadel Advisors
Florida
+$74.4K

Top Sellers

Rank Fund Capital Flow
1
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$938K
2
Morgan Stanley
Morgan Stanley
New York
-$327K
3
Stifel Financial
Stifel Financial
Missouri
-$60K
4
UBS Group
UBS Group
Switzerland
-$23.5K
5
LTFS
Ladenburg Thalmann Financial Services
Florida
-$21.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
Royal Bank of Canada
1
Royal Bank of Canada
Ontario, Canada
$2.92M -$938K -24,646 -23%
SMG
2
Smart Money Group
Texas
$1.88M +$180K +4,724 +10%
Jane Street
3
Jane Street
New York
$966K +$757K +19,902 +256%
FAIM
4
Financial Advocates Investment Management
Washington
$483K +$28.5K +750 +6%
Stifel Financial
5
Stifel Financial
Missouri
$467K -$60K -1,578 -11%
LPL Financial
6
LPL Financial
California
$450K -$5.52K -145 -1%
Citadel Advisors
7
Citadel Advisors
Florida
$384K +$74.4K +1,956 +22%
AWCI
8
Alpine Woods Capital Investors
New York
$297K +$323K +8,500 New
PAG
9
Private Advisor Group
New Jersey
$210K +$229K +6,025 New
LTFS
10
Ladenburg Thalmann Financial Services
Florida
$137K -$21.7K -571 -13%
JP Morgan Chase
11
JP Morgan Chase
New York
$130K -$381 -10 -0.3%
Morgan Stanley
12
Morgan Stanley
New York
$78K -$327K -8,603 -79%
IA
13
IFP Advisors
Florida
$52K – – –
UBS Group
14
UBS Group
Switzerland
$43K -$23.5K -617 -33%
MIFH
15
Migdal Insurance & Financial Holdings
Israel
$34K – – –
FWM
16
Focused Wealth Management
New York
$24K – – –
CFA
17
Carroll Financial Associates
North Carolina
$9K – – –
SWM
18
SeaCrest Wealth Management
New York
$7K – – –
YWP
19
YorkBridge Wealth Partners
New York
$5K – – –

BBP Hedge Fund Activity: Q4 2018 in Review

19 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Virtus Biotech ETF (BBP) for Q4 2018, worth a combined $8.57M — down 21% from $10.9M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new BBP positions and 0 closed out — a net gain of 2 holders — while 4 added to existing stakes and 7 trimmed.

The largest buyer was Jane Street, adding an estimated $757K. The largest seller was Royal Bank of Canada, cutting an estimated $938K.

  • 19 institutional investors held Virtus Biotech ETF (BBP) as of Q4 2018, up from 17 in Q3 2018.
  • Funds reported $8.57M of Virtus Biotech ETF stock for Q4 2018, down 21% quarter-over-quarter.
  • 2 funds opened new Virtus Biotech ETF positions in Q4 2018 and 0 closed out, a net change of +2 holders.
  • The largest Virtus Biotech ETF buyer in Q4 2018 was Jane Street, an estimated $757K added.
  • The largest Virtus Biotech ETF seller in Q4 2018 was Royal Bank of Canada, an estimated $938K sold.

Based on aggregated 13F filings for Q4 2018.